Case Western Reserve University researchers described a mechanistic roadmap for multivalent mRNA-exosome vaccines designed to convert immunologically “cold” tumors into inflamed “hot” ones. The work outlines a platform using personalized mRNA payloads packaged with engineered exosomes to stimulate immune reprogramming and improve responsiveness to cancer immunotherapy.